白鲨vpn
Coronavirus: COVID-19Given the continuing issues globally relating to the COVID-19 pandemic, FIP has taken the decision to transform the Pharmaceutical Sciences World Congress 2023 of May 2023 into a Virtual PSWC 2023. It has been a difficult decision for our association, but one that has been led by responsibility, trust and solidarity: your safety and the well-being of your communities are our priority. The new dates for the Virtual PSWC 2023 will be 4 – 6 October 2023. This will be a completely virtual event, with a combination of live and recorded sessions and a virtual poster gallery, and therefore an excellent opportunity for our worldwide audience to be part of a truly international pharmaceutical sciences event. On the first day we will be also planning the Young Scientist pre-satellite. We are currently working out all the logistics, and we will keep you informed. |
小草破解版app
小草破解版app
白鲨vpn
白鲨vpn
白鲨vpn
白鲨vpn
SEARCH…
Novel concepts
From diseases to clinical candidates. Participants will explore new concepts in our understanding of disease mechanisms, both at the molecular level as well as systems biology levels, and discuss cutting edge approaches to best discover and design appropriate therapeutic modalities, from small molecules to biologics, cell-based therapies or gene-targeted approaches.
小草破解版app
Meeting the challenges of optimal formulation design and manufacture. Participants will discuss how to meet the demands of individualized medicine and global health with cutting-edge formulation, bioanalytical technologies and manufacturing strategies.
Effective translation
From predictive experimental models to optimized clinical studies. Participants will discuss how scientific, technological and regulatory developments can increase success rate in clinical trials and help better individualize treatments, with new predictive experimental models and innovative methods for monitoring treatment exposure and response.
小草破解版app
Societal impact
Developing context-appropriate solutions. Participants will learn how real-world evidence may contribute to address individual patient needs or important public health issues with the efficient implementation of therapeutic innovations in a context-appropriate manner in communities around the world.